Toni Rinow Ph.D., MBA


Dr. Toni Rinow is a catalyst for growth and expansion and is well known for accelerating revenue streams through acquisitions, corporate development, sales and marketing, and financings. With a proven track record of success in international corporate development and the sales and financing of companies in the healthcare market, Toni is quickly becoming a recognized thought leader in healthcare innovation, convergence, and health/IT investments.With a focus on strategic growth, Toni is that rare C-level business manager with blended business expertise and science & engineering brainpower. In addition to her Masters of Business Administration degree (MBA) from McGill University, she holds a doctorate in physical chemistry from the Université de Montréal (Ph.D), and a chemical engineering degree from the European Higher Institute of Chemistry in Strasbourg, France. Her professional career has included leadership roles in both public and private pharmaceutical and healthcare organizations, where she spearheaded acquisitions across Canada, Latin America, and India and supported the transition of two biotechnology companies to an initial public offering at the Toronto Stock Exchange. A forward-thinking negotiator, Toni is primed to support a variety of companies or investors in the healthcare market with strategic global expansion, leveraging a wealth of financing proficiencies. Toni sharpens fiscal decisions and has successfully facilitated the negotiation of international corporate alliances valued over $100M and overseen a life science investment portfolio with $400M under management. She was appointed General Manager of Jubilant DraxImage in 2018, a global leader in nuclear medicine with $200M in sales in 22 countries.